|
NFKBIZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.745740E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.446390E-01 |
| Normal-vs-Stage2 |
3.238000E-03 |
| Normal-vs-Stage3 |
1.062460E-03 |
| Normal-vs-Stage4 |
1.110780E-01 |
| Stage1-vs-Stage2 |
2.943600E-02 |
| Stage1-vs-Stage3 |
4.418300E-03 |
| Stage1-vs-Stage4 |
7.134200E-01 |
| Stage2-vs-Stage3 |
6.454400E-01 |
| Stage2-vs-Stage4 |
1.580980E-01 |
| Stage3-vs-Stage4 |
1.748780E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.888000E-02 |
| Normal-vs-AfricanAmerican |
2.257600E-02 |
| Normal-vs-Asian |
8.033800E-01 |
| Caucasian-vs-AfricanAmerican |
2.551400E-01 |
| Caucasian-vs-Asian |
1.899380E-01 |
| AfricanAmerican-vs-Asian |
5.158000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.495800E-02 |
| Normal-vs-Female |
1.462410E-02 |
| Male-vs-Female |
6.815000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.453000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.144000E-03 |
| Normal-vs-Age(61-80Yrs) |
6.838600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.490600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.343800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.816500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.578600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.617800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.755400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.694000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.194000E-02 |
| Classical-VS-Follicular |
3.633700E-04 |
| Classical-VS-Other |
7.950000E-01 |
| Classical-VS-Normal |
1.469560E-01 |
| Tall-VS-Follicular |
1.467160E-01 |
| Tall-VS-Other |
4.926000E-01 |
| Tall-VS-Normal |
8.140500E-03 |
| Follicular-VS-Other |
3.439800E-01 |
| Follicular-VS-Normal |
3.569300E-04 |
| Other-VS-Normal |
4.152800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.341820E-03 |
| Normal-vs-N1 |
6.957200E-01 |
| N0-vs-N1 |
1.480890E-03 |
|
|
